PMC:7283670 / 43126-43403 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T138","span":{"begin":78,"end":83},"obj":"Body_part"},{"id":"T139","span":{"begin":125,"end":130},"obj":"Body_part"},{"id":"T140","span":{"begin":185,"end":190},"obj":"Body_part"}],"attributes":[{"id":"A138","pred":"fma_id","subj":"T138","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A139","pred":"fma_id","subj":"T139","obj":"http://purl.org/sig/ont/fma/fma7197"},{"id":"A140","pred":"fma_id","subj":"T140","obj":"http://purl.org/sig/ont/fma/fma7197"}],"text":"35.1%, 21.6%, 18.2%, 17.6%, 6.1%, 4.1% in all patients; lower CD4+ and CD8+ T cells: (62.67%)/(56.1%) patients with abnormal liver function received more treatment compared with normal liver function (25%) (p = .009) Fever: (70.1%), cough: (45.3%), expectoration at admission:"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T89","span":{"begin":125,"end":130},"obj":"Body_part"},{"id":"T90","span":{"begin":185,"end":190},"obj":"Body_part"}],"attributes":[{"id":"A89","pred":"uberon_id","subj":"T89","obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"A90","pred":"uberon_id","subj":"T90","obj":"http://purl.obolibrary.org/obo/UBERON_0002107"}],"text":"35.1%, 21.6%, 18.2%, 17.6%, 6.1%, 4.1% in all patients; lower CD4+ and CD8+ T cells: (62.67%)/(56.1%) patients with abnormal liver function received more treatment compared with normal liver function (25%) (p = .009) Fever: (70.1%), cough: (45.3%), expectoration at admission:"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T411","span":{"begin":62,"end":65},"obj":"http://purl.obolibrary.org/obo/PR_000001004"},{"id":"T412","span":{"begin":71,"end":74},"obj":"http://purl.obolibrary.org/obo/CLO_0053438"},{"id":"T413","span":{"begin":76,"end":83},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T414","span":{"begin":125,"end":130},"obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"T415","span":{"begin":125,"end":130},"obj":"http://www.ebi.ac.uk/efo/EFO_0000887"},{"id":"T416","span":{"begin":185,"end":190},"obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"T417","span":{"begin":185,"end":190},"obj":"http://www.ebi.ac.uk/efo/EFO_0000887"}],"text":"35.1%, 21.6%, 18.2%, 17.6%, 6.1%, 4.1% in all patients; lower CD4+ and CD8+ T cells: (62.67%)/(56.1%) patients with abnormal liver function received more treatment compared with normal liver function (25%) (p = .009) Fever: (70.1%), cough: (45.3%), expectoration at admission:"}

{"project":"LitCovid-sentences","denotations":[{"id":"T446","span":{"begin":0,"end":277},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"35.1%, 21.6%, 18.2%, 17.6%, 6.1%, 4.1% in all patients; lower CD4+ and CD8+ T cells: (62.67%)/(56.1%) patients with abnormal liver function received more treatment compared with normal liver function (25%) (p = .009) Fever: (70.1%), cough: (45.3%), expectoration at admission:"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T134","span":{"begin":116,"end":139},"obj":"Phenotype"},{"id":"T135","span":{"begin":218,"end":223},"obj":"Phenotype"},{"id":"T136","span":{"begin":234,"end":239},"obj":"Phenotype"}],"attributes":[{"id":"A134","pred":"hp_id","subj":"T134","obj":"http://purl.obolibrary.org/obo/HP_0002910"},{"id":"A135","pred":"hp_id","subj":"T135","obj":"http://purl.obolibrary.org/obo/HP_0001945"},{"id":"A136","pred":"hp_id","subj":"T136","obj":"http://purl.obolibrary.org/obo/HP_0012735"}],"text":"35.1%, 21.6%, 18.2%, 17.6%, 6.1%, 4.1% in all patients; lower CD4+ and CD8+ T cells: (62.67%)/(56.1%) patients with abnormal liver function received more treatment compared with normal liver function (25%) (p = .009) Fever: (70.1%), cough: (45.3%), expectoration at admission:"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1094","span":{"begin":62,"end":65},"obj":"Gene"},{"id":"1095","span":{"begin":71,"end":74},"obj":"Gene"},{"id":"1157","span":{"begin":46,"end":54},"obj":"Species"},{"id":"1158","span":{"begin":102,"end":110},"obj":"Species"},{"id":"1315","span":{"begin":116,"end":139},"obj":"Disease"},{"id":"1316","span":{"begin":218,"end":223},"obj":"Disease"},{"id":"1317","span":{"begin":234,"end":239},"obj":"Disease"}],"attributes":[{"id":"A1094","pred":"tao:has_database_id","subj":"1094","obj":"Gene:920"},{"id":"A1095","pred":"tao:has_database_id","subj":"1095","obj":"Gene:925"},{"id":"A1157","pred":"tao:has_database_id","subj":"1157","obj":"Tax:9606"},{"id":"A1158","pred":"tao:has_database_id","subj":"1158","obj":"Tax:9606"},{"id":"A1315","pred":"tao:has_database_id","subj":"1315","obj":"MESH:D056486"},{"id":"A1316","pred":"tao:has_database_id","subj":"1316","obj":"MESH:D005334"},{"id":"A1317","pred":"tao:has_database_id","subj":"1317","obj":"MESH:D003371"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"35.1%, 21.6%, 18.2%, 17.6%, 6.1%, 4.1% in all patients; lower CD4+ and CD8+ T cells: (62.67%)/(56.1%) patients with abnormal liver function received more treatment compared with normal liver function (25%) (p = .009) Fever: (70.1%), cough: (45.3%), expectoration at admission:"}